RIMOWA teams up with Swiss furniture designers Vitra for a limited edition collaboration featuring a stool and a toolbox
With mobility and multi-functionality as a daily source of inspiration for RIMOWA and Swiss furniture designers Vitra, the two have come together in a collaboration that provides pieces that can seamlessly integrate into a diverse array of environments.
Image courtesy of RIMOWA.
The collaboration features two limited edition products — the Aluminium Stool and the Aluminium Toolbox.
Image courtesy of RIMOWA.
Image courtesy of RIMOWA.
Image courtesy of RIMOWA.
Image courtesy of RIMOWA.
Jointly developed, the Aluminium Stool is a mobile cube made from RIMOWA's iconic grooved aluminium and equipped with the Maison's Multiwheel system. This seat opens to reveal an interior that has been upholstered with Vitra fabric, offering storage space for all your essentials.
A removable leather divider has also been included to ensure optimal organisation, while the lid's detachable seat cushion provides comfort.
Image courtesy of RIMOWA.
Image courtesy of RIMOWA.
Inspired by the recycled plastic Vitra Toolbox designed by Arik Levy in 2010, the new Aluminium Toolbox is now reimagined with RIMOWA's signature anodised aluminium casing with recycled fabric lining the interior compartments.
Both products are jointly manufactured at RIMOWA and Vitra's respective factories with RIMOWA's aluminium components produced at their headquarters in Cologne and Vitra's upholstered textile elements made at the Vitra Campus in Weil am Rhein.
The Aluminium stool is limited to 1,000 pieces and will be available online at vitra.com and RIMOWA.com starting at 12.15am on 19 June. It will also be available at select RIMOWA flagship stores worldwide.
The Aluminium Toolbox is limited to 100 pieces and will be available exclusively in Europe via RIMOWA.com and worldwide from vitra.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AsiaOne
2 days ago
- AsiaOne
Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News
Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's investments in Singapore to more than US$600 million (S$765 million) since it began operations in Singapore back in 2005. The completed Tuas facility is one of the Swiss-American firm's largest high-tech manufacturing sites with Industry 4.0 capabilities, advanced automation and smart manufacturing systems to meet the increasing global demand for its contact lenses. Amid a growing middle class and rising demand for quality healthcare, the Asia-Pacific region continues to be the fastest-growing market for medical technology, with its market value projected to reach nearly S$300 billion by 2030. This puts the region second only to the US as a source of demand for medical technology (Medtech). "Singapore is home to some of the world's best-in-class Medtech manufacturing palnts. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023. This marks a $5.2 billion increase over the past decade," said Senior Minister of State for Trade and Industry Low Yen Ling at the opening ceremony of Alcon's expanded facility. Beyond strengthening innovation and supply chain resilience within Singapore's MedTech ecosystem, Alcon's investment is also expected to benefit Singaporean workers and small- and medium-sized enterprises (SMEs) in Singapore. Muhammad Haiqal Bin Sapuan, an associate supervisor at Alcon made the switch from the oil and gas industry, through the Career Conversion Programme (CCP), in 2022 to have more time with his family. A year and a half into his role as a senior technician, he was nominated by his peers to step up as an associate supervisor. [[nid:707984]] "That recognition gave me confidence. I started off as an interim, and it was tough at first, but the team's support made the difference," said Haiqal. To date, nearly 180 Singaporean workers have benefitted from the CCP to become Alcon associates. Alcon's new facility is expected to create new job opportunities in production operations, quality control and supply chain management. It is also expected to strengthen innovation and supply chain resilience within Singapore's Medtech ecosystem through initiatives such as the Partnership for Capability Transformation, which partners local SMEs to buiild capabilities from precision moulding to packaging, helping them to scale and compete globally. [[nid:715407]] editor@
Business Times
3 days ago
- Business Times
Roger Federer's long-term deals make him a tennis billionaire
[LONDON] Tennis superstar Roger Federer is now one of the few athletes who can now count themselves a billionaire. Federer, who won 20 Grand Slams between 2003 and 2018, amassed US$130.6 million in prize money during a 24-year playing career that ended in 2022. But the bulk of the Swiss star's wealth has come via a series of bumper sponsorship deals, alongside an astute investment in a local sneaker brand. His net worth is about US$1.3 billion, according to the Bloomberg Billionaires Index, putting him in elite company. Michael Jordan's hit an estimated US$3.5 billion after the sale of his stake in the Charlotte Hornets in 2023, while last year Bloomberg calculated Tiger Woods' wealth at about US$1.36 billion. Federer is worth considerably more than US$1 billion, according to people close to him who spoke on condition of anonymity. Bloomberg's valuation takes into account Federer's career earnings, investments and endorsement deals, adjusted for prevailing Swiss tax rates and market performance. Many of his deals have lasted decades, from sponsorships with Credit Suisse bank (now UBS Group), watchmaker Rolex, and Swiss chocolatier Chocoladefabriken Lindt & Sprungli. Federer has also built a close advice network around him, including through Team8, the management company he co-founded with longtime agent Tony Godsick in 2013, and also Swiss firm Format A, which helps manage various investments and his charitable foundation. 'Federer is totally scandal free. He never says the wrong thing,' sports analyst Bob Dorfman said. 'He hasn't been a John McEnroe, feisty personality type. But in terms of marketability, he's been one of tennis's best.' A NEWSLETTER FOR YOU Friday, 2 pm Lifestyle Our picks of the latest dining, travel and leisure options to treat yourself. Sign Up Sign Up Federer's biggest deals came near the end of his career. By 2018, a rolling contract with Nike – first signed in 1996 – had come up for renewal. Tennis was not a core market for Nike, allowing Godsick to test the water with other potential partners. Uniqlo, a popular brand owned by Japan's Fast Retailing, offered Federer US$300 million over 10 years to be one of its flagship sports icons. Federer was 37 and close to retirement and the deal had no strings attached, even if he stopped playing. It was a no-brainer. Still, it was not Federer's most successful deal. That was an investment that came via an accidental introduction by his wife, who bought a pair of sneakers from up-and coming Swiss brand On. There are plenty of bankers and lawyers in Switzerland, but not many sports brands. Founded in 2010, On had become known as a high-end jogging shoe. Its distinctive sole, with more empty space than rubber, was based off a prototype made by co-founder Olivier Bernhard – a former pro-Ironman – taping offcuts of garden hose to the base of his trainers. Unlike with Nike, Federer could hunt for a footwear sponsor because Uniqlo does not make shoes. A sneaker nut who owns well over 250 pairs of trainers (not including ones he played in), Federer called On's founders for dinner in Zurich. Godsick also had a connection with them via an angel investment in the firm. Eventually, a deal was struck for Federer to buy a roughly 3 per cent stake in On Holding and to spend time in its lab designing his own shoe. On is now worth close to US$17 billion, making Federer's stake at least US$500 million, according to Bloomberg's wealth index. Federer has so far avoided overexposure via commentary roles or dubious sponsorships. He recently waved the French flag to start the Le Mans endurance car race, and launched a new Uniqlo clothing collection in Paris. He's also likely to be at Wimbledon – home to his greatest triumphs – when it begins next week. BLOOMBERG
Business Times
3 days ago
- Business Times
Swiss-American eye care firm Alcon launches expanded Tuas manufacturing facility
[SINGAPORE] Alcon, a Swiss-American pharmaceutical and medical device company specialising in eye care products, opened its expanded manufacturing and logistics facility in Tuas on Friday (Jun 27). This brings its total investment in Singapore to more than US$600 million since opening its first manufacturing site here in 2005. Located in Tuas Biomedical Park, the facility is one of Alcon's largest manufacturing sites, featuring advanced automation, smart manufacturing systems and industry 4.0 capabilities to support the increasing global demand for its contact lenses. It is also designed for operational efficiency and sustainability, with automation; digital systems; and features that reduce energy use, water consumption and waste. It has achieved zero waste to landfill and supports scalable production for global demand. Speaking at the launch event, Senior Minister of State for Trade and Industry Low Yen Ling said the partnership between Alcon and Singapore over the past 20 years exemplifies how deep, sustained collaboration can drive industrial growth and create meaningful careers for Singaporeans. 'Singapore is home to some of the world's best-in-class medtech manufacturing plants. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023, a nearly fourfold increase over the past decade,' she said. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up In a statement, Alcon said that the expansion is expected to create new 'high-value' jobs in areas such as manufacturing, quality control and distribution management. It will also support Singapore's ambition to grow its medtech workforce, which comprises over 400 companies and employs more than 16,000 people as of 2024. The company partners with local institutions and workforce programmes to build skills in precision engineering, biomedical sciences and artificial intelligence automation, supporting the growth of Singapore's medtech sector. One initiative is the Career Conversion Programme (CCP), which allowed the firm to tap into a broader, more diverse talent pool, including mid-career switchers and individuals seeking new roles. To date, nearly 180 associates have benefited. Muhammad Haiqal Sapuan, a beneficiary of the programme, worked in the oil and gas sector previously and joined Alcon as a senior technician in 2022. After participating in the CCP and undergoing strong mentoring, he now serves as an associate supervisor, leading a team of 15 in production technical operations. Alcon currently employs more than 25,000 people worldwide and serves over 260 million patients across 140 countries annually.
